6.08
price up icon6.11%   0.35
after-market Handel nachbörslich: 6.00 -0.08 -1.32%
loading
Schlusskurs vom Vortag:
$5.73
Offen:
$6
24-Stunden-Volumen:
21,890
Relative Volume:
1.38
Marktkapitalisierung:
$23.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.56M
KGV:
-0.3615
EPS:
-16.82
Netto-Cashflow:
$-12.46M
1W Leistung:
+7.23%
1M Leistung:
+0.52%
6M Leistung:
+7.61%
1J Leistung:
+89.41%
1-Tages-Spanne:
Value
$5.616
$6.35
1-Wochen-Bereich:
Value
$5.34
$6.75
52-Wochen-Spanne:
Value
$2.80
$7.89

Tenax Therapeutics Inc Stock (TENX) Company Profile

Name
Firmenname
Tenax Therapeutics Inc
Name
Telefon
919-855-2100
Name
Adresse
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Name
Mitarbeiter
6
Name
Twitter
@TenaxThera
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
TENX's Discussions on Twitter

Vergleichen Sie TENX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TENX
Tenax Therapeutics Inc
6.08 23.83M 0 -14.56M -12.46M -16.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.82 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
520.29 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.82 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.53 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
267.12 28.51B 3.81B -644.79M -669.77M -6.24

Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-24 Eingeleitet Leerink Partners Outperform
2024-10-14 Eingeleitet Guggenheim Buy
2024-09-30 Eingeleitet William Blair Outperform
2017-05-18 Hochstufung Ladenburg Thalmann Neutral → Buy
2014-12-16 Eingeleitet MLV & Co Buy
2014-11-18 Eingeleitet WallachBeth Buy
Alle ansehen

Tenax Therapeutics Inc Aktie (TENX) Neueste Nachrichten

pulisher
Jun 17, 2025

Tenax Therapeutics Approves Officer Exculpation Amendment - TipRanks

Jun 17, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Acquires Shares of 13,521 Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Acquires New Holdings in Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

When (TENX) Moves Investors should Listen - news.stocktradersdaily.com

Jun 10, 2025
pulisher
May 29, 2025

Where are the Opportunities in (TENX) - news.stocktradersdaily.com

May 29, 2025
pulisher
May 23, 2025

Tectonic, Tenax, others aim for shift in heart failure - BioWorld MedTech

May 23, 2025
pulisher
May 20, 2025

Tenax Therapeutics Reports Increased Losses Amid Strategic Investments - TipRanks

May 20, 2025
pulisher
May 19, 2025

Roth Capital Issues Negative Forecast for TENX Earnings - Defense World

May 19, 2025
pulisher
May 19, 2025

William Blair Cuts Earnings Estimates for Tenax Therapeutics - Defense World

May 19, 2025
pulisher
May 19, 2025

Leerink Partnrs Brokers Boost Earnings Estimates for TENX - Defense World

May 19, 2025
pulisher
May 18, 2025

(TENX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 18, 2025
pulisher
May 18, 2025

What is William Blair’s Estimate for TENX FY2028 Earnings? - Defense World

May 18, 2025
pulisher
May 18, 2025

Roth Capital Has Bearish Forecast for TENX FY2028 Earnings - Defense World

May 18, 2025
pulisher
May 16, 2025

Tenax Therapeutics (NASDAQ:TENX) Now Covered by StockNews.com - Defense World

May 16, 2025
pulisher
May 16, 2025

Tenax Therapeutics: Q1 Earnings Snapshot - Bluefield Daily Telegraph

May 16, 2025
pulisher
May 16, 2025

Tenax Therapeutics (TENX) Projects Funding Through 2027 | TENX S - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Analyst Adjusts Tenax Therapeutics (TENX) Price Target, Maintains Buy Rating | TENX Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Tenax Therapeutics (TENX) Advances Phase 3 Studies in 2025 | TEN - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Tenax Therapeutics Inc Reports Q1 2025 Net Loss of $10.4 Million Amid Rising R&D and Administrative Expenses - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Tenax Therapeutics (TENX) Projects Funding Through 2027 | TENX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Tenax Advances Breakthrough PH-HFpEF Treatment: Phase 3 Trial Updates and $111M War Chest Revealed - Stock Titan

May 14, 2025
pulisher
May 11, 2025

Tenax Therapeutics (TENX) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

(TENX) Technical Data - news.stocktradersdaily.com

May 08, 2025
pulisher
May 08, 2025

Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com - Defense World

May 08, 2025
pulisher
May 05, 2025

Geode Capital Management LLC Boosts Stock Position in Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World

May 05, 2025
pulisher
May 02, 2025

Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated at StockNews.com - Defense World

May 02, 2025
pulisher
Apr 25, 2025

Form SC 13G/AStatement of Beneficial Ownership by Certain Investors: [Amend] - ADVFN

Apr 25, 2025
pulisher
Apr 25, 2025

SEC Form DEF 14A filed by Tenax Therapeutics Inc. - Quantisnow

Apr 25, 2025
pulisher
Apr 25, 2025

Form DEF 14A TENAX THERAPEUTICS, INC. For: Apr 24 - StreetInsider

Apr 25, 2025
pulisher
Apr 24, 2025

Tenax Therapeutics Advances Cardiopulmonary Therapies - TipRanks

Apr 24, 2025
pulisher
Apr 22, 2025

Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - The Globe and Mail

Apr 22, 2025
pulisher
Apr 21, 2025

Oxygen Biotherapeutics, Inc. : Oxygen Biotherapeutics Announces Third Quarter FY2013 Financial Results Conference Call and Webcast - marketscreener.com

Apr 21, 2025
pulisher
Apr 17, 2025

Teanx Therapeutics plans secondary offering - MSN

Apr 17, 2025
pulisher
Apr 16, 2025

Tenax: Phase 3 Heart Failure Program Continues With 2 Key Catalysts - Seeking Alpha

Apr 16, 2025
pulisher
Apr 16, 2025

Tenax Therapeutics (TENX) Files Prospectus for Stock Resale - GuruFocus

Apr 16, 2025
pulisher
Mar 31, 2025

Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 31, 2025
pulisher
Mar 31, 2025

Exclusive: Tenax Leadership Team to Unveil Latest Phase 3 Progress at Major Healthcare Conference - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

What is Leerink Partnrs’ Forecast for TENX Q1 Earnings? - Defense World

Mar 31, 2025
pulisher
Mar 29, 2025

Equities Analysts Offer Predictions for TENX Q1 Earnings - Defense World

Mar 29, 2025
pulisher
Mar 29, 2025

Q1 Earnings Estimate for TENX Issued By William Blair - Defense World

Mar 29, 2025
pulisher
Mar 29, 2025

Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Research Analysts Set Expectations for TENX Q1 Earnings - Defense World

Mar 28, 2025

Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.52
price down icon 1.06%
$35.91
price down icon 0.64%
$21.27
price up icon 1.67%
$104.85
price down icon 0.99%
$104.80
price down icon 0.28%
biotechnology ONC
$267.12
price up icon 0.12%
Kapitalisierung:     |  Volumen (24h):